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The development of the central nervous system requires the coordination of proliferation and 19 
differentiation of neural stem cells. Here, we show that laminin alpha 2 (lm-2) is a 20 
component of the midbrain dopaminergic (mDA) progenitor niche in the ventral midbrain 21 
(VM) and identify a concentration-dependent role for lm211 in regulating mDA progenitor 22 
proliferation and survival via distinct set of receptors.  At high-concentrations, lm211 rich 23 
environments maintain mDA progenitors in a proliferative state via integrins α6β1 and α7β1.  24 
Whereas low concentrations of lm211 support mDA lineage survival via dystroglycan 25 
receptors.  We confirmed our findings in vivo where, in the absence of lm-2, the VM was 26 
smaller, with increased apoptosis, and the progenitor pool depleted through premature 27 
differentiation resulting in fewer mDA neurons.  In examining mDA neuron subtype 28 
composition we found a reduction in later-born mDA neurons of the ventral tegmental area, 29 
which control a range of cognitive behaviours. Our results identify a novel role for lm in 30 
neural development and provide a possible mechanism for autism-like behaviours and 31 
brainstem hypoplasia seen in some patients with mutations of the human lm-2 gene. 32 
 33 
Keywords: Extracellular matrix, neural stem cells, laminin, integrin, dystroglycan, 34 
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 2 
Introduction 38 
During development, the embryonic central nervous system (CNS) consists of proliferating 39 
neural stem cells (NSCs) that are exposed to a balance of intrinsic and extrinsic factors that 40 
regulate cell fate decisions (1,2).  One such extrinsic determinant is the extracellular matrix 41 
(ECM), a multifunctional network of proteins interacting with and regulating a range of cell 42 
functions.  Transcriptional analysis of mouse and human neocortices display an enrichment 43 
of ECM genes such as laminins (lms), proteoglycans and integrins in the germinal zones 44 
suggesting they may play a role in regulating NSC behaviour (3,4).   45 
 46 
Lms are high-molecular weight, heterotrimeric glycoproteins composed of an α, β and γ 47 
chain.  Currently 5α, 3β and 3γ chains have been identified combining to form at least 16 48 
different combinations in the mouse, creating considerable tissue heterogeneity.  Mutations 49 
to the human gene (lama2) encoding the lm-α2 protein results in merosin-deficient muscular 50 
dystrophy (MDC1A)(5–7).  Whilst this congenital muscular dystrophy (CMD) results primarily 51 
in skeletal muscle damage, patients often exhibit a broad spectrum of neuroanatomical 52 
defects including white matter abnormalities, cerebellar cysts and brainstem (midbrain, pons 53 
and medulla) hypoplasia (8,9). However, the specific functions of lm-α2, particularly in the 54 
developing CNS, that lead to these brain abnormalities in MDC1A are unknown. 55 
 56 
A further set of clinical symptoms seen in these patients includes neurological deficits in 57 
executive functions, intellectual disability and attention deficit hyperactive disorder (ADHD) 58 
(8–11). This phenotype highlights a possible involvement of the ventral domain of the 59 
midbrain, consisting of dopaminergic (mDA) neurons that can be subdivided into two main 60 
nuclei: substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA). SNc 61 
mDA neurons are generated first, project largely to the striatum and contribute to the control 62 
of voluntary movement, with the selective death of these neurons being the pathological 63 
hallmark of Parkinson’s disease (PD) (12). In contrast, later-born VTA mDA neurons 64 
innervate the hippocampus and the prefrontal cortex (PFC) regulating a range of cognitive 65 
functions (13).  A dopamine imbalance in the VTA mDA neurons has been implicated in the 66 
aetiology of ADHD, obsessive-compulsive disorder (OCD), addiction and schizophrenia (14–67 
16). 68 
 69 
In this study, we have explored the role of lm-α2 protein in NSC development, focussing on 70 
the hypothesis that mutations in lama2 gene disrupt mDA neurogenesis resulting in a 71 
dopamine imbalance that may contribute to some of the neuropsychiatric deficits found 72 
amongst CMD patients.  We first confirm the expression of lm-α2 in the human embryonic 73 
ventral midbrain (VM) during mDA neurogenesis.  We then utilised a human embryonic stem 74 
(hES) cell model of mDA differentiation to define a functional role for lm-α2 in mDA 75 
progenitor proliferation and survival.  Finally, we confirmed our findings in vivo using a lm-α2 76 
null transgenic mouse model.  Our findings show that lm-α2 regulates NSC behaviour by 77 
controlling the survival of mDA progenitors and their timely differentiation into neurons.  In 78 
the absence of lm-α2, mDA progenitors are prematurely depleted resulting in a reduction in 79 
the number of late-born mDA neurons in the VTA.  80 
 81 
Results 82 
Lm-α2 is present in the developing human VM surrounding mDA progenitors 83 
 3 
Using immunohistochemistry (IHC), chain-specific lm expression in the mesencephalon of 84 
human embryos at 6-10 post-conception weeks (pcw) revealed the early embryo (6 pcw) to 85 
be rich in lm-α2 (fig 1).  The VM was immuno-positive for lm-α2 throughout the entire apico-86 
basal axis surrounding a population of rapidly dividing (Ki67+) mDA progenitors.  Analysis of 87 
a previously published single-cell RNA sequencing (scRNA-seq) study of the human VM 88 
between 6-11 pcw suggests that pericytes are a potential contributing cell source and could 89 
potentially secrete this lm into the interstitial space (fig 1) (17).  A developmental time-course 90 
analysis revealed that protein expression diminished over time and by 10 pcw, lm-α2 91 
expression was largely absent from the human VM.  Similarly, in the mouse VM, lm-α2 92 
protein expression rapidly diminished after E10.5 with little or no detectable lm-α2 at E14.5 93 
(fig S1).  The loss of interstitial lm-α2 expression correlated with the loss of proliferating mDA 94 
progenitors, suggesting a potential role for lm-α2 in supporting self-renewal.  Examination of 95 
the spatiotemporal expression patterns of the remaining four lm-α chains revealed the basal 96 
laminae of the blood vessels within the VM to be rich in lm-α4 (fig S1), consistent with the 97 
scRNA-seq data showing expression to be greatest in endothelial cells and pericytes.  98 
Expression of the lm-α1 was most pronounced in the basement membrane lining the basal 99 
surface of the neural tube whereas lm-α5 could be seen on the ventricular surface and 100 
interspersed around the cells of the VM.  This again is consistent with the scRNA-seq data 101 
showing expression of these laminin genes in radial glial cells (Rgl – whose processes span 102 
the two surfaces of the developing mesencephalon) and progenitors (fig S1).  Lm-α3 protein 103 
and mRNA expression were absent in the midbrain floor plate, underlining the specificity of 104 
the different laminin expression patterns.  105 
 106 
Lm211 regulates the balance between proliferation and differentiation in a 107 
concentration-dependent manner and controls the survival of human mDA 108 
progenitors 109 
To assess the functional role of lm-α2, a hES cell model of mDA differentiation was 110 
established (fig S2) using a previously published protocol capable of yielding mDA neurons 111 
positive for a range of markers such as TH, Nurr1, DDC, Pbx1a, Girk2 and Calb1 (fig S2) 112 
(18).  Day 14 VM progenitors that are positive for FoxA2+, Lmx1a+ and Otx2+ (fig S2), 113 
analogous to mDA progenitors in vivo at 6pcw, were incubated with the recombinant version 114 
of the lm-α2 containing trimeric protein, lm211, at a concentration ranging from 0.5-12 μgml-1 115 
for a period of 14 days.  The thymidine analogue, EdU, was administered prior to fixation to 116 
label proliferating cells and the cultures were stained for tyrosine hydroxylase (TH), which 117 
marks mDA neurons.  Increasing concentrations of lm211 increased the number of mDA 118 
progenitors that were EdU+, with a concomitant reduction in the number of TH+ mDA 119 
neurons (fig 2A-C).   120 
 121 
Focussing on two concentrations favouring proliferation (4 μgml-1) and differentiation (1 122 
μgml-1), the differentiation dynamics were interrogated further.  Cultures were fixed at day 123 
21, 28 and 35 and were examined for proliferation (EdU), differentiation (Nurr1 and TH) and 124 
cell death (active caspase 3, aC3).  No differences were detected at day 21 between either 125 
conditions; however, the lm211-rich environment (4μgml-1) sustained cells in a proliferative 126 
state (fig 2D) and consequently delayed differentiation resulting in fewer Nurr1+ post-mitotic 127 
neuroblasts (fig 2E) and TH+ neurons (fig 2F) being detected at day 28 and 35 compared to 128 
lm211-poor condition (1μgml-1).  Whilst the number of apoptotic cells increased over the 129 
duration of the culture, no significant difference was detected between the two lm211 130 
concentrations (fig 2G).   131 
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Having shown a role for lm211 in promoting VM progenitor proliferation, we next determined 132 
whether this property was specific to the lm-α2 isoform by treating the cultures with three 133 
other lm isoforms – lm111, lm411 and lm511 – at the previously identified concentrations (1 134 
and 4 μgml-1).  Rates of proliferation of mDA progenitors were the same on all lm isoforms, 135 
with no significant difference detected in EdU labelling at either concentration (fig S3A, B, 136 
D).  Similarly, no effect on the number of TH+ cells was detected at high concentrations of 137 
lm-α isoforms (fig S3E). Surprisingly, however, a significant increase in the number of TH+ 138 
neurons was detected on lm211 at low concentration, compared to the other three isoforms 139 
(fig S3C).  We therefore next determined whether this increase in TH+ neurons on low 140 
concentrations of lm211 was due to enhanced differentiation or survival by examining aC3 141 
immunoreactivity (a marker of apoptosis) on the four different lm isoforms.  Significantly 142 
fewer aC3+ cells were seen on lm211 (fig S3F) suggesting the increase in the number of 143 
mDA neurons is due to improved cell survival.  Taken together, these results suggest lm211 144 
has distinct concentration-dependent effects, with a lm-rich environment supporting 145 
proliferation and expansion of the progenitor pool irrespective of isoform, whilst low 146 
concentrations of lm-α2 containing isoform promote survival of mDA lineage cells. 147 
 148 
Interaction of Lm211 and human mDA progenitors is mediated by distinct receptor 149 
engagement 150 
To identify the cell surface receptors responsible for the different effects of lm-α2 on mDA 151 
progenitors, we used a functional blocking antibody approach.  As the lm-rich environment 152 
maintains cells in a proliferative state irrespective of isoform, we speculated that the integrin 153 
family of receptors were involved.  Three principle lm-binding integrins have been identified: 154 
α3β1, α6β1 and α7β1.  All were expressed in the hVM; scRNA-seq analysis showed that the 155 
radial glia (hRgl) and midline progenitors (hProgM) express significant levels of α6 integrin 156 
and detectable levels of α7 and β1 integrins (fig S4).  We further confirmed the presence of 157 
these three integrin subunits via immunostaining hES cell derived mDA progenitors (fig S4). 158 
Blocking the β1 integrin subunit resulted in a complete loss of adhesion and cell detachment 159 
(data not shown) whilst blocking the individual α-subunits had a negligible effect on mDA 160 
progenitor proliferation (fig 3B).  As the integrin α-subunits may functionally compensate for 161 
each other, we next blocked pairwise combinations of α-subunits.  Blocking α3 integrin had 162 
no discernible effect, but the combined blockade of both integrin α6 and α7, in the presence 163 
of 4μgml-1 lm211, resulted in the loss of the lm211-driven increase in EdU+ mDA progenitors 164 
and an increase in the number of TH+ mDA neurons (fig 3B and 3C).  We further confirmed 165 
the role of integrin α6 and α7 in mediating the proliferative response by blocking both 166 
receptors in the presence of lm111, lm411 and lm511 at 4μgml-1 and successfully reversing 167 
the increase in proliferating mDA progenitors (fig S5).   168 
 169 
As the previously seen increased cell survival of hES derived mDA lineage cells (fig S3C 170 
and G) was specific to low concentrations of lm-α2, we speculated that dystroglycan – a 171 
high-affinity lm-α2 receptor enriched in the floor plate, point of origin of mDA neurons, may 172 
be mediating the effect (19–21).  We confirmed the expression of dystroglycan in the hVM 173 
via immunostaining and also in the scRNA-seq dataset, in which it is expressed at significant 174 
levels in hRgl (fig S4).  Blocking dystroglycan with a targeted antibody (IIH6C4) in vitro 175 
reversed the laminin-isoform specific increase in TH+ neurons seen on low-concentrations of 176 
lm211 to levels comparable to those seen on lm111 (fig 3D-F).  When we administered the 177 
antibody without any exogenous lm211, we did not observe any significant differences in 178 
TH+ cells confirming the lm-specific nature of the interaction (fig S5). 179 
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 180 
A loss of progenitors and premature differentiation results in reduced number of 181 
neurons in the ventral midbrain of Lm-2 null mice   182 
Together, results using human cells and tissue suggest the hypothesis that the fall in lm-2 183 
expression levels in the human VM between 6 and 10pcw controls VM NSC cell cycle exit 184 
and mDA neuron differentiation, with the lower concentrations of lm-2 then supporting cell 185 
survival. To confirm that lm-a2 is such an instructive component of the niche in vivo, we 186 
examined the VM of lm-α2 null mouse embryos during mDA neurogenesis at embryonic (E) 187 
day 10.5-14.5, corresponding to 6-10pcw in humans.  We first confirmed that the lm-α2 null 188 
embryos do not express lm-α2 (fig S6).   189 
 190 
Our hypothesis predicts that in the absence of lm-α2 there would be fewer mDA progenitors 191 
and more neurons due to the loss of the proliferative effect of this laminin, resulting in 192 
premature differentiation. This was confirmed; the lama2-/- embryos were smaller than the 193 
WT littermate controls and the ventral midbrain (VM) domain, demarcated by FoxA2 194 
expression, consisted of significantly fewer cells (fig S7A-D).  Premature differentiation at 195 
E10.5 could be detected in the lama2-/- embryos as evidenced by increased number of 196 
Nurr1+ and TH+ cells at this age, with a concomitant reduction in proliferating VM 197 
progenitors (double Ki67+ and FoxA2+ cells) (fig 4A-D).  Nascent mDA neurons were seen 198 
not only in the marginal zone along the basal surface of the VM but also in ectopic positions 199 
at the ventricular surface of the lama2-/- VM (fig S8) – a region where the high concentration 200 
of lm-2 would normally prevent differentiation.   201 
 202 
To exclude the possibility that the observed reduction in size of the VM resulted from 203 
patterning defects rather than changes in proliferation, we examined the position of cells 204 
expressing FoxA2, Lmx1a or Corin and calculated the area of their domains, normalised to 205 
the area of the ventricle.  No significant difference in position or domain sizes was seen at 206 
E10.5 or E12.5 (fig S7), suggesting patterning is unaffected in the mutant embryos. We also 207 
examined the expression patterns of Nkx6-1 and Wnt1 in wild-type and mutant embryos at 208 
E12.5 and found no differences (fig S7H,I). We did however note a slight delay in the lateral 209 
expansion and medial inhibition of Shh expression, with low levels of Shh in the mutant 210 
basal plate compared with the controls (fig S7I).  This finding is in agreement with both the 211 
known function of Shh to control the expansion of the VM (22,23) and with our findings of 212 
decreased number of FoxA2+ cells (figS7K), impaired growth and reduced proliferation in the 213 
VM.   214 
 215 
Our original hypothesis also predicts increased levels of apoptosis due to the loss of the 216 
survival-promoting effect of low concentrations of lm-2.  Again, this was confirmed; by 217 
E12.5 numerous active caspase 3+ (aC3) cells were found along the border of the 218 
ventricular zone and intermediate zone that separates progenitors from postmitotic 219 
neuroblasts, suggesting that apoptosis takes place during cell-cycle exit (fig 4E).  220 
Quantification revealed a near two-fold increase in aC3+ cells and fewer FoxA2+ progenitors 221 
(double Foxa2+ and KI67+ cells) in the VM (fig 4F, J).  222 
 223 
Ectopic TH+ neurons were once again detected at the ventricular surface of the mutant VM 224 
at E12.5 (fig S8).  However, in contrast to the situation at E10.5, by E12.5 the intermediate 225 
and marginal zone of the lama2-/- embryos contained fewer Nurr1+ and TH+ cells (fig 4H 226 
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and I). To determine the cause of this reduction in neuron number, we next examined the 227 
expression of the proneural gene Ngn2 in Lmx1a+ mDA progenitors (24).  Whilst these 228 
experiments confirmed the reduction of midbrain floor plate mDA progenitors, identified as 229 
Lmx1a+, we found no significant difference in the subset of progenitors undergoing 230 
neurogenesis, identified as Ngn2+, in the lama2-/- embryos (fig 4L).  Consequently, we 231 
conclude that the proportion of progenitors undergoing neurogenesis is greater in the mutant 232 
embryos, leading to accelerated differentiation and depletion of the progenitor pool.  To test 233 
this directly, we injected pregnant mice subcutaneously with EdU at E11.5 and dissected the 234 
embryos 24 hours later at E12.5.  We then quantified the number of dividing cells (EdU+) 235 
that had exited cell cycle and were positive for the post-mitotic marker Nurr1.  Confirming 236 
our previous results, we found a significant increase in neurogenesis with a 26% increase in 237 
the number of cells positive for both EdU and Nurr1 in the mutant embryos compared with 238 
wild-type littermate controls.  Meanwhile, there was a significant decrease in the number of 239 
Lmx1a+ EdU+ cells that are Nurr1- (i.e. mDA progenitors that are still in cell cycle).  240 
Consistent with this, by E14.5, there were significantly fewer TH+ neurons in the mutant 241 
embryos than in the WT littermate controls (fig S9).   242 
 243 
To determine whether these effects are restricted to the mDA lineage, we next examined 244 
non-mDA neurons in the VM.  Brn3a is a marker of neurons within the red nucleus, 245 
immediately lateral to the mDA neuron domain.  The number of Brn3a+ neurons in lama2-/- 246 
mutants were significantly reduced compared to wild-type littermate controls at E14.5 (fig 247 
S10), indicating that basal plate neurogenesis is also impaired.   248 
 249 
Lm-2 null mice have fewer Calbindin+ mDA VTA neurons 250 
Birth-dating experiments have demonstrated that mDA neurons are born sequentially with 251 
more lateral mDA neurons that project to the striatum born first and the medial mDA neurons 252 
projecting to the PFC, born later in development (25,26).  To examine how the altered 253 
differentiation dynamics in the mutant embryos affects the distribution and subtype 254 
composition of mDA neurons in the postnatal brain we examined the expression of Girk2 255 
and Calbindin (Calb1), markers expressed predominantly in the lateral SNc mDA neurons 256 
and the medial VTA mDA neurons respectively at postnatal (P) day 15.  Both subpopulations 257 
of TH+ mDA neurons can be identified in the VM of both WT and mutant brains, with the 258 
Calbindin+/TH+ cells clustered around the ventral midline whereas the Girk2+/TH+ cells are 259 
distributed more laterally (fig 5).  A small sub-section of mDA neurons expressing both Girk2 260 
and Calbindin were found largely restricted to the dorsolateral VTA in the transition zone 261 
between the SNc and VTA.  The lama2-/- brains were found to be smaller at P15 (fig S11) 262 
and to have fewer TH+ mDA neurons in the midbrain compared to WT littermate controls (fig 263 
5A).  The loss of neurons was particularly apparent in the mediocaudal VM (fig S12), 264 
suggesting that the later-born medial mDA neurons were preferentially depleted in the 265 
mutant mice.  Quantifying Girk2 and Calbindin expression confirmed this, revealing a 266 
reduction in the number of TH+ Calbindin+ (later-born) mDA neurons with no significant 267 
decrease in the number of Girk2+ TH+ (early-born) mDA neurons (fig 5B-C).  As expected, 268 
quantification of the ratio of TH+ mDA neurons that are either Girk2 or Calbindin+ in the 269 
mutant brains revealed proportionately more Girk2+ and fewer Calbindin+ mDA neurons (fig 270 
5D).  These results suggest that premature depletion of the mDA progenitor pool, due to a 271 
smaller progenitor domain combined with accelerated differentiation and increased 272 
apoptosis, leads to a loss of late-born Calbindin positive mDA neurons creating an 273 
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In this study, we describe the expression and distribution of laminin isoforms in the mouse 278 
and human VM and then identify a dual functional role for one of these, lm-α2, in controlling 279 
cell cycle exit and survival in the mDA neuron lineage.  We propose a model whereby the 280 
lm-α2 rich environment, found early in development, sustains VM progenitor proliferation via 281 
an integrin-dependent pathway.  As lm-α2 expression diminishes, cells are able to exit from 282 
the cell cycle and differentiate with low levels of lm-α2 then promoting the survival of 283 
progenitors through dystroglycan receptors.  In mutant lama2-/- mice, the loss of lm-α2 284 
protein results in a smaller mDA progenitor pool that is subsequently depleted by a 285 
combination of increased cell death and premature differentiation, leading to a defect in late 286 
generated mDA neurons of the VTA subtype.   287 
 288 
Previous studies examining lm expression in the brain describe the murine neocortex as 289 
being rich in lm-α2 and lm-α4, with expression greatest at the ventricular surface (3,27).  290 
Moreover, the subventricular zone, one of two adult stem cell niches in the CNS, was found 291 
to be a lm-rich environment compared to neighbouring non-neurogenic regions suggesting 292 
lms may play a role in regulating NSC self-renewal (28).  Consistent with this, we find the 293 
presence of high levels of interstitial lm-α2 in the early human embryo during a period of 294 
rapid growth, after which levels decline.  Three other laminin isoforms, lm-α1, lm-α4 and lm-295 
α5 were largely restricted to the basal lamina.  Together, our immunostaining and analysis of 296 
a previously-published scRNA-seq dataset reveals lm expression to be highly specific and 297 
dynamically regulated over the course of development.   298 
 299 
Several independent studies have implicated the lm-integrin interaction in controlling NSC 300 
proliferation in both the embryonic cortex and in the adult stem cell niches (29–32).  301 
Additionally, in pathological conditions characterised by rapid proliferation such as 302 
glioblastoma multiforme (GBM), the cellular niche has been described to be rich in lm-α2 303 
whilst the glioblastoma stem-like cells that drive tumour growth are enriched with integrin α6 304 
and α7 (33–35).  Disruption of the lm-integrin interactions in GBM significantly impaired 305 
tumour growth (33–35). Given our results showing the expression of lm-α2 in mDA 306 
progenitors maintains cells in a proliferative state, it would be interesting to test the 307 
hypothesis that a common mechanism underpins the lm-integrin driven NSC proliferation in 308 
embryonic, adult and pathological conditions. Identifying downstream mechanisms as well 309 
as positive and negative regulators of lm expression could be important not only to control 310 
proliferation in cancer, but also in a regenerative context, offering the potential to counteract 311 
the age-dependent decline in NSC self-renewal.    312 
 313 
Over the course of development, laminin expression diminishes and is restricted to the 314 
ventricular zone, limiting the cells it can interact with to those rapidly dividing progenitors 315 
juxtaposed to the surface of the ventricle.  The interaction with lm-α2 in this region prevents 316 
exit from the cell cycle and differentiation.  As predicted from this hypothesis, in the complete 317 
absence of lm-α2 precocious mDA neurons can be seen at both the basal surface and 318 
ectopically at the ventricular surface.  An increase in the number of apoptotic cells in the 319 
interface between the ventricular and intermediate zone can also been seen, reflecting the 320 
requirement for lower concentrations of lm-α2 to maintain the survival of the newly-321 
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postmitotic cells in this region.  A previous study identified that lm-α5 driven YAP activation 322 
promotes the survival of mDA neurons in the marginal zone (36), at a later differentiation 323 
stage compared to the one described in this study.  Interestingly, lm-α2 has also been 324 
reported to activate YAP and further upregulate the expression of lm receptors such as 325 
integrins and dystroglycan in Schwann cells (37), suggesting a possible interaction between 326 
these two lm-activated pathways and a general role of lms in controlling cell survival at 327 
different developmental stages along the same lineage.  Indeed, it is perfectly feasible that 328 
the lm511 present in the VM may be compensating for the loss of lm211, masking the extent 329 
of the phenotype.   330 
 331 
We have previously shown that the principal lm receptor, integrin 1, is capable of regulating 332 
both NSC self-renewal and differentiation in the chick midbrain via distinct mechanisms (38).  333 
Meanwhile, the relative abundance of the lm protein has been shown to control the balance 334 
between quiescence and activation in epidermal stem cells (39). Our present results extend 335 
these prior studies by showing a concentration-dependent effect of lm-α2 controls the 336 
proliferation and survival of human progenitors, at least in part, by sequential receptor 337 
engagement with integrins and dystroglycan.   It is interesting to note that a similar interplay 338 
between the two receptors has been identified in lm-mediated pancreatic β-cell development 339 
(40).  Moreover, αβ integrins and dystroglycan have been shown to act sequentially during 340 
Schwann cell development in the peripheral nervous system (PNS), activating different 341 
signalling pathways during axonal sorting (41).  In agreement with these previously 342 
published studies, the data presented here suggests that the two lm receptors are 343 
responsible for distinct steps during mDA development.  How lm-211 is able to regulate 344 
these specific processes in a concentration-dependent manner remains an open question.  345 
One possible explanation may lie in receptor affinities.  Previously published solid-phase 346 
binding assays of lm211 with dystroglycan and a number of α-integrins demonstrated that 347 
the dystroglycan interaction is an order of magnitude greater than with integrins (42,43), and 348 
so is likely to be favoured at the lower lm concentrations later in the developmental process. 349 
 350 
Mutations affecting lm-α2, dystroglycan and more rarely integrin α7 result in CMD, a 351 
clinically and genetically heterogeneous group of disorders affecting primarily muscle and 352 
brain.  Neurological deficits that includes structural malformations and cognitive impairment 353 
are most abundant in patients carrying mutations affecting dystroglycan (44,45).  However, a 354 
number of patients carrying a lama2 mutation also report neurological abnormalities 355 
including brainstem hypoplasia (8,9).  In the lm-α2 null embryos described in this study, we 356 
found a VM significantly reduced in size likely due to the impairment of proliferation, 357 
premature differentiation and increased cell death resulting in a depletion of the progenitor 358 
pool; a phenotype reminiscent of integrin β1 mutant mice in which cerebellar granule cell 359 
precursors cease proliferating and differentiate prematurely (46).  Interestingly, impaired Shh 360 
signalling contributed to the premature differentiation in integrin β1 mutant mice following 361 
disruption of the integrin-laminin-Shh complex (46). Moreover, Shh-proteoglycan interactions 362 
were previously shown to be necessary for regulating proliferation but dispensable for tissue 363 
patterning (47). As we find a defect in proliferation but with correct patterning and a subtle 364 
delay in Shh expression in lm-α2 null embryos, a contribution of Shh signalling to the 365 
proliferation phenotype cannot be excluded. 366 
 367 
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A well-established consequence of premature differentiation and depletion of the progenitor 368 
pool is a loss of later-born neurons (48–50).  In accordance with these studies, we found a 369 
disruption of mDA neuron subtype composition, with a reduction in the later-born, Calbindin 370 
positive mDA neurons of the VTA.  The mDA neurons of the VTA project to the caudal 371 
brainstem, hippocampus and PFC and play an important role in a number of processes 372 
including cognition, motivation and attention related behaviour.  Indeed a subset of these 373 
late-born mDA neurons project almost exclusively to the GABAergic interneurons of the PFC 374 
and regulate perseveration-like behaviour (51).  This loss of late-born neurons may 375 
contribute to the cognitive defects described in the few published reports of behavioural and 376 
psychiatric problems in MDC1A patients.  Of potentially more importance, however, is the 377 
possibility that abnormalities in the laminin-dystroglycan-dystrophin pathway caused by 378 
dystrophin mutations in Duchenne muscular dystrophy (DMD) patients may, by altering mDA 379 
neuron production, contribute to the high prevalence for ADHD and autism spectrum 380 
disorder (ASD) described in a recent study on 130 Duchenne muscular dystrophy (DMD) 381 
patients (10).  In keeping with this, a separate study reported a reduction in GABAA receptor 382 
clustering in the PFC – a target of the late-born mDA neurons – of 14 DMD patients (52).  383 
Given the roles we have ascribed to lm-α2, a more thorough behavioural and psychiatric 384 
analysis of MDC1A patients would be of great value and provide some support to the notion 385 
that a dopamine imbalance underpins the behavioural deficits observed in muscular 386 
dystrophies.    387 
 388 
Methods 389 
Human and mouse tissue processing 390 
OCT Tissue-Tek embedded human foetal midbrain tissue (5-10 pcw) was obtained from the 391 
MRC-Wellcome Trust Human Developmental Biology Resource (HDBR).  Sequential 392 
coronal sections covering the length of the mesencephalon were collected on superfrost 393 
glass slides (ThermoFisher) using a cryostat (ThermoFisher). 394 
 395 
All mouse experiments were conducted following the procedures approved by Roswell Park 396 
Institute Animal Care and Use Committee (UB1188M, UB1194M, and UB1196R). The 397 
protocols follow the guidelines of the “Guide For The Use of Laboratory Animals,” National 398 
Research Council, National Academy Press, Washington D.C., 1996.  All animals used in 399 
this work were congenic into the C57/BL6N background and genotyping of Lama2 mutant 400 
mice was done by PCR of tail genomic DNA. Briefly, PCRs were done 45s at 95°C, 45s at 401 
50°C, and 60s at 72°C for 30 cycles. The primers used were as follows: 5’-402 
CCCGTGATATTGCTGAAG-3’, 5’-CCTCTCCATTTTCTAAAG-3’ and 5’-403 
CAGGTGTTCCAGATTGCC-3’. The lama2 mutant used in this study was the dy3k mutant 404 
comprising a complete knockout of the laminin alpha 2 protein (53). 405 
 406 
To obtain embryos, matings were set late in the evening and plugs checked the next 407 
morning before 9 AM with those that were positive designated as E0.5.  At E10.5, E12.5 and 408 
E14.5, pregnant mice were sacrificed. E10.5 whole mount embryos and the dissected heads 409 
of E12.5 and E14.5 embryos were fixed in 4% PFA overnight at 4°C.   410 
 411 
From the EdU labelling studies, pregnant mice were subcutaneously injected with 50mg/kg 412 
of 5-Ethynyl-2′-deoxyuridine (EdU, Sigma 900584) at E11.5.  Embryos were dissected 24 413 
hours later at E12.5. 414 
 415 
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Embryos were washed in PBS (3×5mins) and incubated in 15% sucrose (Sigma) in PBS at 416 
4°C overnight. The embryos were then placed in embedding solution that consisted of 15% 417 
sucrose and 7% gelatin (Sigma) in PBS at 37°C for a period of 2 hours.  Finally, the embryos 418 
were placed in moulds and orientated for coronal sections and snap frozen in liquid N2 and 419 
stored at -80°C.  10μm serial sections spanning the length of the midbrain were taken from 420 
each sample.  Two embryos from 2-3 different litters were analysed for each time-point 421 
(N=4-6).  Individual figure captions make clear the N used for each experiment. 422 
 423 
In the case of P15 brains, animals were anesthetized with 20 mg/ml Avertine (2,2,2-424 
tribromoethanol, Sigma, T48402) and sequentially perfused through the left ventricle with ice 425 
cold 1X PBS and 4% PFA. Next, the brains were dissected and post fixed in 4% PFA 426 
overnight at 4˚C and transferred to 30% sucrose for 48 hours at 4°C and snap frozen in 427 
liquid N2.  20μm sections were collected on glass slides.  Two brains from two different litters 428 
were examined for both mutant and control animals (N=4). 429 
 430 
Cell cultures 431 
Undifferentiated RC17 ES cells (passages 23-58, Roslin Cells, hPSC reg #RCe021-A) were 432 
maintained in E8 media (A1517001) on Geltrex (1%, 12760021) coated plates and 433 
passaged weekly with EDTA (0.5 mM). To start differentiation (day 0), hESC colonies were 434 
detached using EDTA (0.5 mM) and placed in non-treated 60mm culture dishes in 435 
differentiation media consisting of DMEM:F12/Neurobasal (1:1), N2 supplement (1:100), B27 436 
supplement (1:50), SB431542 (10uM, Tocris Biosciences), rhnoggin (100 ng/ml, R&D), 437 
SHH-C24II (200 ng/ml, R&D) and CHIR99021 (0.9 μM, Tocris Biochem). Media was 438 
changed once on day 2. The resultant embryoid bodies were collected on day 4 and placed 439 
on polyornithine (PO), fibronectin (Fn) and laminin (lm) coated plates in reduced N2 (1:200) 440 
and B27 (1:100) condition. Growth and patterning factors were removed on day 9 with the 441 
cultures kept in DMEM:F12/Neurobasal (1:1), N2 supplement (1:200), B27 supplement 442 
(1:100). On day 11, the cell clusters were dissociated to single cells with accutase and 443 
replated onto dry PO/Fn coated plates for differentiation in Neurobasal, B27 (1:50), BDNF 444 
(20 ng/ml), GDNF (10 ng/ml), AA (200 μM), db-cAMP (0.5 mM, Sigma).  All culture reagents 445 
are from Invitrogen unless otherwise stated here or previously. 446 
Experiments were conducted from day 14, where cultures were treated with soluble lm 447 
isoform (BioLamina) or vehicle, with each media change, for stated period of time.  Media 448 
was changed every third day until fixation in 3.7% PFA for 30 minutes.  Where stated, an 449 
EdU pulse was administered for 24 hours prior to fixation to identify dividing cells.   450 
Receptor blocking antibodies or isotype controls were added to the culture media at 5 μg/ml 451 
(10 μg/ml for dystroglycan) and refreshed every 3 days with each media change.  Antibodies 452 
used were: integrin α3 IA3 (R&D MAB1345-SP), integrin α6 GoH3 (R&D MAB13501), 453 
integrin α7 6A11 (LifeSpan Biosciences, LS-C179572), Dystroglycan IIH6C4 (Millipore, 05-454 
593), mouse-IgM (ThermoFisher, 02-6800), rat-IgG2a (ThermoFisher, 02-9688), mouse-455 
IgG1 (ThermoFisher, 02-6100). 456 
 457 
Immunofluorescence, microscopy & image quantification 458 
List of antibodies used, suppliers and dilutions are provided in table S1. 459 
 460 
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Human and mouse sections were boiled in antigen unmasking solution (Vector Labs) and 461 
pre-incubated at room temperature for 1 hour in blocking solution containing 10% normal 462 
donkey serum (Millipore), 1% bovine serum albumin (Sigma), 0.2% Triton X-100 (Sigma).  463 
Sections were incubated with primary antibodies diluted in blocking solution at 4°C overnight 464 
followed by washing with blocking solution (3×15mins).  Sections were then incubated with 465 
fluorophore conjugated secondary antibodies (Invitrogen) diluted 1:1000 in blocking solution 466 
for 1 hour at room temperature, followed by washing (3×15mins), hoechst nuclear counter 467 
stain (10mins at room temperature) and mounted (Fluoromount, SouthernBiotech).   468 
 469 
The Operetta high-content microscope (PerkinElmer) was used for automated image-470 
acquisition of cell cultures that were then quantified using automated quantification pipelines 471 
developed using Columbus Image Analysis Software (PerkinElmer).   472 
 473 
Meanwhile, tissue sections (both embryonic and P15) were imaged on an SP8 confocal 474 
microscope (Leica) and quantified manually using Fiji CellCounter plug-in.  For quantification 475 
of embryonic tissue, adjacent sections were used for labelling (FoxA2, Ki67, Nurr1 and TH) 476 
and 5 sections spanning the anterior-posterior axis were counted per stain and sample.  For 477 
P15 brain, TH+ mDA neurons were quantified in sections at three rostrocaudal levels 478 
(Bregma: -2.92mm, -3.40mm and -3.88mm).  TH+, TH+ Girk2+ and TH+ Calbindin+ cells 479 




RNAscope mRNA detection was performed according to the manual, using the 484 
RNAScope 2.5 HD reagent Kit-RED (ACD, 322350). PFA fixed sections (10μm) were 485 
dehydrated in an ethanol gradient (50%, 70% and 100%) and incubated with H2O2 for 10 486 
min.  Sections were washed in deionized water and then boiled for 5 minutes in antigen 487 
retrieval solution then transferred to a dish containing distilled water.  After washing, 488 
slides were rinsed in fresh 100% ethanol and air dried.  RNAscope Protease plus was 489 
applied to the slides and incubated for 30 mins at 40°C.  Slides were then washed in 490 
distilled water with slight agitation.  The appropriate RNAscope probe (Shh: cat no 491 
314361, Wnt1: cat no 401091) was then applied to the slide and incubated for 2 hours at 492 
40°C.  Sections were then washed in wash buffer and the colour reaction was performed 493 
according to the user manual.  Sections were counterstained for 1 min with haematoxylin 494 
(Scientific Laboratories, GHS132-1L), and the blue reaction was performed using 0.02% 495 
ammonia water. Sections were dried at 60 °C and mounted. 496 
 497 
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Fig 1: Lm-α2 expression in the human ventral midbrain at 6 and 10 pcw. 674 
Lm-α2 expression (antibody: C13065) is enriched in the human VM at 6pcw, when the hVM is 675 
composed of Ki67+ FoxA2+ progenitors. Expression diminishes by 10pcw when the hVM contains 676 
few Ki67+ cells and post-mitotic Nurr1+ mDA neurons are established. scRNA-seq of the hVM 677 
suggests pericytes (hPeric) are the principle source of Lm-a2 (Right axis shows absolute molecule 678 
counts). Scale bar 50 μm.  679 
 680 
Fig 2: Lm211 regulates proliferation and differentiation in a concentration dependent manner. 681 
(A) Immunostaining of day 28 hES derived mDA cultures treated with lm211 over a concentration 682 
range of 0.5-12 μgml-1. Quantification of EdU (B) and TH (C) staining showing a significant increase in 683 
proliferating (EdU+) cells at lm211 concentrations of over 4μgml-1 which is associated with a reduction 684 
in TH+ mDA neurons (One-way ANOVA with Tukeys post-test, p<0.0001, n=3). (D-G) Time series 685 
examining proliferation (D) differentiation (E, F) and survival (G) at days 21, 28 and 35 of culture at 686 
two different lm211 concentrations. mDA progenitors remain EdU+ at day 28 and 35 in the lm211-rich 687 
(4μgml-1) environment, resulting in a significant reduction in the number of post-mitotic mDA 688 
neuroblasts (Nurr1) and neurons (TH). No significant differences in aC3 staining between the two 689 
lm211 concentrations (unpaired, two-tailed t-test, * p<0.0001, n=3). (H) Representative images of day 690 
35 cultures following lm211 treatment. Scale bar 50 μm in all images.  691 
 692 
Fig 3: Concentration-dependent effects of lm211 are mediated by distinct receptor 693 
engagement  694 
(A) Immunostaining of day 28 cultures treated with lm211 (4 μgml-1) in combination with integrin 695 
blocking antibodies and a control condition of lm211 (1 μgml-1). Quantification of proliferation (B) and 696 
differentiation (C) following blocking of integrin a-subunit demonstrating that blocking both a6 and a7 697 
integrins reverses the effect of the lm211-rich environment. (D) Images of day 28 cultures treated  698 
with lm isoforms (1 μgml-1) and dystrolgycan blocking antibody or isotype control. Quantification of 699 
proliferation (E) and differentiation (F) demonstrating blockade of dystroglycan reverses the gain in 700 
mDA neurons seen on lm211 compared to lm111 without effecting proliferation. *p<0.0001, unpaired 701 
two-tailed t-test, n=3. Scale bar 50 μm in all images.  702 
 703 
Fig 4: Lm-α2 null VM is reduced in size with fewer cells and exhibits premature differentiation 704 
and depletion of progenitor pool 705 
Representative images and quantification of wild-type and mutant VMs at (A-D) E10.5 and (E-M) 706 
E12.5. At E10.5, mutant embryos display a smaller ventral domain indicated by FoxA2 staining. 707 
Fewer FoxA2+ cells are Ki67+ in the lama2-/- embryo (B) with increased numbers of post-mitotic mDA 708 
neuroblasts (Nurr1+) and mDA neurons (TH+) quantified in (C) and (D) respectively. By E12.5, there 709 
remains fewer proliferating FoxA2+ cells (F) and Lmx1a+ cells (G) in the VM of mutant embryos.  The 710 
intermediate and marginal zones of the mutant VM contain fewer Nurr1+ (H) and TH+ (I) cells whilst 711 
there is an increase in apoptotic (aC3+) cells at the ventricular zone and intermediate zone border in 712 
the absence of lm-α2.  Whilst there is a reduction in the number of Lmx1a+ mDA progenitors (L), the 713 
number of Lmx1a+ Ngn2+ cells remains the same resulting in a greater proportion of progenitors 714 
undergoing neurogenesis (12.51 ± 0.89% (WT) vs 20.73 ± 3.49 % (lama2-/-)) in the mutant embryos.  715 
EdU labelling confirmed this with a significant increase in the number of EdU+ Nurr1+ cells in the 716 
mutant embryos (512 ± 41 (WT) vs 663 ± 88 % (lama2-/-)) whereas there was a significant decrease in 717 
the number of Lmx1a+ EdU+ cells that are Nurr1- (201 ± 35 (WT) vs 116 ± 26 (lama2-/-)).  N=4-6, two 718 
tailed unpaired t-test, *p<0.01, scale bar 50μm.  719 
Fig 5: The midbrain of lm-α2 null brains contains fewer late-born Calbindin+ mDA neurons of 720 
the VTA 721 
Postnatal brains (P15) of wild-type and mutant mice showing fewer TH+ mDA neurons (A) in the 722 
lama2-/- brains. In quantifying mDA subtype, there is a modest reduction in the number of Girk2+ mDA 723 
neurons (B) but a dramatic loss in Calbindin+ mDA neurons (C) located medially in the VM. In 724 
normalising for the number of mDA neurons (D), there is a significant increase (p=0.0033) in the 725 
proportion of Girk2+ TH+ mDA neurons in the mutant mice concomitant with a reduction (p=0.0105) in 726 
Calbindin+ TH+ mDA neurons. N=3 (WT), 4(KO), unpaired two-tailed t-test. Scale bar 100μm unless 727 
stated.  728 
Fig S1: Lm-α chain immunohistochemistry in human VM  729 
(A) Lm-α1 expression is restricted to the basement membrane surrounding the basal surface neural 730 
tube. Lm-a3 is not expressed in the human VM. Lm-a4 is restricted to the basal laminae of blood 731 
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vessels at both 6 and 10 pcw. Meanwhile lm-a5 is expressed on both the ventricular and basal 732 
surfaces of the VM at 6 pcw as well as some interstitial expression. (B) scRNA-seq data of individual 733 
lm-a chains showing cell types for gene expression in human development. Right axis shows absolute 734 
molecule counts. (C) Lm-α2 expression in the mouse VM at E10.5-E14.5 displays a similar 735 
expression pattern as that seen in the human embryo.  Expression can be seen to diminish over time 736 
with negligible positive expression at E14.5. 737 
 738 
Fig S2: Differentiation protocol and patterning of hES cells into mDA progenitors  739 
(A) schematic of hES differentiation protocol with lm treatment at day 14 till fixation. (B) 740 
Immunostainings of day 11 cultures showing cultures to be triple positive for the mDA progenitor 741 
markers FoxA2, Lmx1a and Otx2. Cultures are negative for the pluripotency marker Oct4, forebrain 742 
marker Pax6 and the lateral domain marker Nkx6.1. (C) TH+ Neurons at day 35 showing positive 743 
immunoreactivity for a panel of markers (Nurr1, Pbx1a, DDC, Calb1, Girk2) illustrative of bona fide 744 
mDA neurons. Scale bar 50μm.  745 
 746 
Fig S3: Lm isoform specificity in regulating mDA progenitor proliferation and survival  747 
(A) Representative images of mDA cultures at day 28 exposed to lm211 at 1 and 4 μgml-1, staining for 748 
proliferation (EdU) and neurons (TH). At low concentrations (1 μgml-1), no significant difference in 749 
proliferation (B) is detected between any of the lm isoforms whilst an increase in TH+ mDA neurons 750 
(C) is observed on lm211. At high concentrations (4 μgml-1), no differences are detected in the 751 
number of mDA progenitors that are EdU+ (D) or TH+ (E). *p<0.001, ANOVA Tukeys post test, N=3  752 
 753 
Fig S4: Expression of lm receptors 754 
Integrins α6, α7, β1 and Dystroglycan are expressed in the mouse VM and on hES derived mDA 755 
progenitors at day 14 of culture. scRNA-seq of the hVM identifies radial glial (hRgl1-3) and VM 756 
progenitors (hProg) positive for lm receptor expression. Right axis shows absolute molecule counts. 757 
Scale bar 50μm.  758 
 759 
Fig S5: Specificity of laminin-receptor interactions 760 
(A) Integrin α6 and α7 blocked with antibodies in the presence of 4 μgml-1 of lm111, lm411 and lm511.  761 
When cultures are exposed to the integrin blocking antibodies, the lm-driven increase in proliferation 762 
is abrogated suggesting that the integrin receptors are mediating the proliferative effects of lm.  (B) 763 
Blocking the α-dystroglycan receptor with no exogenous lm211 does not effect the number of TH+ 764 
neurons generated. N=3, two-tailed unpaired t-test, *p<0.001. 765 
 766 
Fig S6: Lm-α2 expression in the wild-type and lama2-/- mouse VM 767 
No Lm-α2 expression can be detected in the lama2-/- embryos confirming the knock-out. 768 
 769 
Fig S7: Lama2-/- exhibit defects in growth but normal patterning  770 
(A) Cross-sections of wild-type and lama2-/- mesencephalon at E10.5 (scale bar 100 μm) with the 771 
mutant mesencephalon significantly smaller in area (B).  The dopaminergic domain consisting of 772 
FoxA2, Lmx1a and Corin (scale bar 50 μm).  Fewer FoxA2 cells are present in the lama2-/- midbrain 773 
(D).  The area of each domain was calculated and normalised to the area of the ventricle.  No 774 
significant differences were detected in the size of the normalised FoxA2 (E), Lmx1a (F) and Corin 775 
(G).  Nkx6-1+ cells can be seen laterally and are induced in both the mutant and wild-type embryo at 776 
E10.5 (scale bar 50 μm) (H).  Potential ectopic expression and a delay in the lateral expansion 777 
and medial inhibition of Shh expression in the mutant embryos at E12.5 can be seen.  Wnt1 778 
expression is comparable to wild-type and previously published reports (scale bar 100 μm) (I).  779 
Dopaminergic domain remains smaller at E12.5 (scale bar 50 μm) (J) in the mutant embryo compared 780 
to wild-type, consisting of fewer FoxA2 cells (K) but when normalised for ventricle size, there are no 781 
significant differences in FoxA2 (L), Lmx1a (M) or Corin (N) domain size.  N=4-6, two-tailed unpaired 782 
t-test. 783 
 784 
Fig S8: Ectopic mDA neurons in the VM of lama2-/- embryos  785 
TH+ mDA neurons can be seen lining the ventricular surface of lm-α2 null embryos at E10.5 (orange 786 
arrows). Ectopic mDA neurons (orange arrowhead) at the ventricular surface (dashed line) continue to 787 
be observed at E12.5. Scale bar 50 μm.  788 
 789 
Fig S9: Reduced mDA neurons in the VM at E14.5  790 
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Significantly fewer TH+ mDA neurons in the VM of mutant embryos compared to wild-type littermate 791 
controls. N=6, two-tailed unpaired t-test, scale bar 50 μm.  792 
 793 
Fig S10: Development of non-mDA VM neurons compromised in lama2-/- mutants.  794 
Brn3a+ red nucleus neurons, derived from FoxA2+ progenitors, are significantly reduced in the 795 
mutant embryos compared to wild-type littermate controls at E14.5. N=6, two-tailed unpaired t-test, 796 
scale bar 50μm.  797 
 798 
Fig S11: Smaller mutant brains compared to wild-types at P15 799 
Lama2-/- brains are significantly smaller than WT littermate controls, quantified via mass. N=4, two- 800 
tailed unpaired t-test. 801 
 802 
Fig S12:  VM of wild-type and mutant P15 brains showing reduced number of neurons 803 
Large panels are images of the whole VM from wild-type and lama2-/- P15 brains along the rostral-804 
caudal axis showing reduced TH+ immunoreactivity (white) in the mutant brains (scale bar 100 μm).  805 
Images to the side are expanded view of the red boxes displaying TH (white) and Calb1 (red) (scale 806 
bar 50 μm).  Fewer TH+ Calb1+ double positive cells can be seen in the mutant brains, particularly in 807 
the more caudal sections. 808 
 809 
